153 related articles for article (PubMed ID: 31640952)
1. [Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of
Shen L; Lin J; Wang B; Xu H; Zhao K; Zhang L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Sep; 39(9):1107-1112. PubMed ID: 31640952
[TBL] [Abstract][Full Text] [Related]
2. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients.
Jia M; Yu S; Cao L; Sun PL; Gao H
Ann Surg Oncol; 2020 Aug; 27(8):3052-3063. PubMed ID: 32048092
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathological study of lung adenocarcinomas with pure ground-glass opacity > 3 cm on high-resolution computed tomography.
Sun K; Xie H; Zhao J; Wang B; Bao X; Zhou F; Zhang L; Li W
Eur Radiol; 2022 Jan; 32(1):174-183. PubMed ID: 34132876
[TBL] [Abstract][Full Text] [Related]
5. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography.
Xiang W; Xing Y; Jiang S; Chen G; Mao H; Labh K; Jia X; Sun X
Cancer Imaging; 2014 Nov; 14(1):33. PubMed ID: 25608623
[TBL] [Abstract][Full Text] [Related]
6. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.
Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T
Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966
[TBL] [Abstract][Full Text] [Related]
7. CT features and quantitative analysis of subsolid nodule lung adenocarcinoma for pathological classification prediction.
Li X; Zhang W; Yu Y; Zhang G; Zhou L; Wu Z; Liu B
BMC Cancer; 2020 Jan; 20(1):60. PubMed ID: 31992239
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung.
Yotsukura M; Asamura H; Motoi N; Kashima J; Yoshida Y; Nakagawa K; Shiraishi K; Kohno T; Yatabe Y; Watanabe SI
J Thorac Oncol; 2021 Aug; 16(8):1312-1320. PubMed ID: 33915249
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C
Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172
[TBL] [Abstract][Full Text] [Related]
10. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma.
Yagi T; Yamazaki M; Ohashi R; Ogawa R; Ishikawa H; Yoshimura N; Tsuchida M; Ajioka Y; Aoyama H
Jpn J Radiol; 2018 Feb; 36(2):113-121. PubMed ID: 29273964
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dynamic image progression of minimally invasive and preinvasive lung adenocarcinomas.
Chen T; Zhang X; Campisi A; Ciarrocchi AP; Dell'Amore A; Song L; Yang Y; Chen C; Luo Q
Ann Transl Med; 2021 May; 9(9):804. PubMed ID: 34268417
[TBL] [Abstract][Full Text] [Related]
12. Association between quantitative spectral CT parameters, Ki-67 expression, and invasiveness in lung adenocarcinoma manifesting as ground-glass nodules.
Wu N; Cao QW; Wang CN; Hu HG; Shi H; Deng K
Acta Radiol; 2023 Apr; 64(4):1400-1409. PubMed ID: 36131377
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Quantitative Spectral CT Parameters and Ki-67 Expression in Lung Adenocarcinomas Manifesting as Ground-glass Nodules.
Cao X; Hu HG; Shen M; Deng K; Wu N
Curr Med Imaging; 2023; 19(9):1052-1062. PubMed ID: 36588337
[TBL] [Abstract][Full Text] [Related]
14. Changes in quantitative CT image features of ground-glass nodules in differentiating invasive pulmonary adenocarcinoma from benign and in situ lesions: histopathological comparisons.
Zhang YP; Heuvelmans MA; Zhang H; Oudkerk M; Zhang GX; Xie XQ
Clin Radiol; 2018 May; 73(5):504.e9-504.e16. PubMed ID: 29329732
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less
Petterson J; Mustafa D; Bandaru S; Eklund EÄ; Hallqvist A; Sayin VI; Gagné A; Fagman H; Akyürek LM
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474205
[TBL] [Abstract][Full Text] [Related]
16. [Value of PET/CT Combined with CT Three-dimensional Reconstruction
in Distinguishing Different Pathological Subtypes of Early Lung Adenocarcinoma].
You J; Zhang G; Gao X; Chen Y; Shu Y
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):468-474. PubMed ID: 34120430
[TBL] [Abstract][Full Text] [Related]
17. A radiomics study to predict invasive pulmonary adenocarcinoma appearing as pure ground-glass nodules.
Cai J; Liu H; Yuan H; Wu Y; Xu Q; Lv Y; Li J; Fu J; Ye J
Clin Radiol; 2021 Feb; 76(2):143-151. PubMed ID: 33187676
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of contrast-enhanced CT scans in identifying lung adenocarcinomas manifesting as ground glass nodules].
Sun YL; Gao F; Gao P; Jin L; Li C; Hua YQ; Li M
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):534-538. PubMed ID: 30060363
[No Abstract] [Full Text] [Related]
19. CT-texture analysis of subsolid nodules for differentiating invasive from in-situ and minimally invasive lung adenocarcinoma subtypes.
Cohen JG; Reymond E; Medici M; Lederlin M; Lantuejoul S; Laurent F; Toffart AC; Moreau-Gaudry A; Jankowski A; Ferretti GR
Diagn Interv Imaging; 2018 May; 99(5):291-299. PubMed ID: 29477490
[TBL] [Abstract][Full Text] [Related]
20. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
